Dec 11, 2019 | Non classé
The treatment, approved for use in 31 countries, is now being marketed in Germany, Italy, Israel and Mexico 29.04.2019 TOOKAD® optic fibers illuminate only the cancerous regions, leaving healthy tissue alone Steba Biotech, a privately-owned company, in collaboration...
Nov 22, 2019 | Non classé
Weizmann study may show the way BRIEFS DATE: NOVEMBER 19, 2019 A vaccine that protects against Ebola—one of the world’s deadliest viral diseases—was recently approved by the European Medicines Agency (EMA), the first time any immunization against Ebola has passed this...
Nov 22, 2019 | Non classé
A lively conversation with the Weizmann Institute’s incoming President Q&A DATE: OCTOBER 23, 2019 Prof. Alon Chen Prof. Alon Chen enters office as the next President of the Weizmann Institute on December 1. A world-renowned neuroscientist with a focus on...
Nov 18, 2019 | Non classé
DATE: OCTOBER 23, 2019 Prof. Daniel Zajfman Prof. Daniel Zajfman The new Nature survey, in which Weizmann was ranked #2 in research quality, indicates that the ‘Weizmann recipe’ is a good one: small but serious institutions are highly effective. What are the...
Recent Comments